1-4 of 4
Eszter Nagy
Close
Sort by
Journal Articles

The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1

Fathima Zumla Cader, Martina Vockerodt, Shikha Bose, Eszter Nagy, Marie-Anne Brundler, Pamela Kearns, Paul G. Murray
Journal: Blood
Blood (2013) 122 (26): 4237–4245.
https://doi.org/10.1182/blood-2013-04-499004
Published: 2013
Includes: Supplemental data
Journal Articles

The EBV Oncogene LMP1 Protects Lymphoma Cells From Cell Death Through The Collagen-Mediated Activation Of Discoidin Domain Receptor 1

Fathima Zumla Cader, PhD, MBChB, MRCPCH, Martina Vockerodt, PhD, Shikha Bose, PhD, Eszter Nagy, BSc, Marie-Anne Brundler, MD, Pamela R Kearns, MBChB, PhD, FRCPCH, Paul G Murray, PhD
Journal: Blood
Blood (2013) 122 (21): 4241.
https://doi.org/10.1182/blood.V122.21.4241.4241
Published: 2013
Journal Articles

Novel Large Deletion Is the Most Frequent Cause of Type 3 von Willebrand Disease in Hungary.

Adrien Mohl, MD, Tamás Masszi, MD, PhD, Eszter Nagy, PhD, Tobias Obser, Florian Oyen, Krisztina Sallai, Imre Bodo, MD, PhD, Reinhard Schneppenheim, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1013.
https://doi.org/10.1182/blood.V108.11.1013.1013
Published: 2006
Journal Articles

Increased Clearance Explains the Ultra-Large Multimers in Von Willebrand Disease Type 2M Vicenza; Lessons from Recombinant VWF Vicenza and Modeling of Multimer Catabolism.

András Gézsi, Gábor Balázsi, Krisztina Sallai, Adrienn Mohl, Eszter Nagy, PhD, Teréz Szabó, MD, J. Evan Sadler, MD, PhD, Imre Bodó, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3669.
https://doi.org/10.1182/blood.V104.11.3669.3669
Published: 2004